Scarica l'app Stockscreener
8.88
0.23%
0.02
Dopo l'orario di chiusura:
8.88
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Prothena Corp Plc Borsa (PRTA) Ultime notizie
HC Wainwright Issues Positive Estimate for Prothena Earnings - MarketBeat
Prothena (PRTA) Stock Shrugs Off Revenue Drop As Pipeline Stakes Rise - Sahm
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus - Yahoo Finance
Prothena (NASDAQ:PRTA) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Prothena: Q2 Earnings Snapshot - marketscreener.com
Prothena (NASDAQ: PRTA) turns H1 2026 profit on $50M milestone - Stock Titan
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights - marketscreener.com
FMR LLC discloses 13.8% Prothena (PRTA) ownership; key fund holds 6.4% - Stock Titan
Renaissance Technologies LLC Has $5.91 Million Stock Position in Prothena Corporation plc $PRTA - MarketBeat
Prothena (NASDAQ:PRTA) Insider Anne Evans Kingston Sells 7,662 Shares of Stock - MarketBeat
Prothena Corp PLC (PRTA) Chief Strategy Officer Anne Kingston Se - GuruFocus
Prothena to Report Second Quarter 2026 Financial Results on August 6 - Yahoo Finance
BlackRock (PRTA holder) discloses 6.9% beneficial stake in Prothena common stock - Stock Titan
Prothena Corp. Plc Revenue Breakdown – LSX:A1KAVV - TradingView
Rubric Capital Management LP Has $48.60 Million Position in Prothena Corporation plc $PRTA - MarketBeat
Prothena (PRTA) Expected to Announce Quarterly Earnings on Monday - MarketBeat
PRTA|Prothena Corporation PLC|Price:8.720|Chg%:-0.030 - TradingKey
Prothena stock trades steady as Alzheimer portfolio advances and earnings show growing R&D investmen - Ad-hoc-news.de
Trading the Move, Not the Narrative: (PRTA) Edition - Stock Traders Daily
Michael John Isaacs Net Worth (2026) - GuruFocus
Prothena (PRTA) Price Target Increased by 37.50% to 16.83 - msn.com
PRTA Stock Rises Nearly 11% in Six Months: What's Driving It? - Yahoo Finance
Prothena Corp plc updates investors on pipeline progress as neurodegeneration focus deepens - ad-hoc-news.de
Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider - GlobeNewswire Inc.
PRTAProthena Corp Plc Options - Finviz
Price to sales forward of Prothena Corp. Plc – MUN:0PT - TradingView
Enterprise value to revenue forward of Prothena Corporation plc – NASDAQ:PRTA - TradingView
Enterprise value to EBIT forward of Prothena Corporation plc – NASDAQ:PRTA - TradingView
Price to book forward of Prothena Corp. Plc – MUN:0PT - TradingView
Enterprise value to EBITDA forward of Prothena Corp. Plc – MUN:0PT - TradingView
Enterprise value to revenue forward of Prothena Corp. Plc – MUN:0PT - TradingView
Prothena Corp, Parkinson antibody program draws attention for the stock - ad-hoc-news.de
Prothena Corp. Plc Actuals & Estimates (NASDAQ:PRTA) - TradingView
Prothena Corp. Plc Actuals & Estimates (DUS:0PT) - TradingView
Prothena Corp. Plc Actuals & Estimates (SWB:0PT) - TradingView
PRTA Forecast — Price Target — Prediction for 2027 - TradingView
0PT Forecast — Price Target — Prediction for 2027 - TradingView
Prothena Corporation PLC (PRTA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Prothena Corporation Plc (NASDAQ:PRTA) About To Shift From Loss To Profit - Moomoo
Prothena Corp plc strategy in focus, shares watched against biotech peers - AD HOC NEWS
Prothena Corporation PLC (PRTA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Prothena Corporation PLC (PRTA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prothena Corporation PLC (PRTA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Prothena Corporation PLC (PRTA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Price-Driven Insight from (PRTA) for Rule-Based Strategy - Stock Traders Daily
(PRTA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
PRTA Q1 2026 Earnings: Surprise EPS Beat Driven by Milestone Revenue, Stock Edges HigherDownward Estimate Revision - The Legal Advocate
(PRTA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Penbrook Management LLC's Prothena Corp PLC(PRTA) Holding History - GuruFocus
Prothena (NASDAQ: PRTA) investors approve board, KPMG and executive pay - Stock Titan
Rubric Capital and David Rosen disclose 9.29% stake in Prothena (PRTA) - Stock Titan
Prothena Corp plc stock (IE00B91XRN20): Biotech investor focus amid pipeline updates - AD HOC NEWS
Number of shareholders of Prothena Corp. Plc – DUS:0PT - TradingView
PRTA Stock Price, Quote & Chart | PROTHENA CORP PLC (NASDAQ:PRTA) - ChartMill
William Scully reports 10.27% stake in PROTHENA (NASDAQ: PRTA) - Stock Titan
Prothena Corp. Down Over 9%, on Pace for Largest Percent Decrease Since May 2025 -- Data Talk - Moomoo
Earnings Beat: Prothena Corporation plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Prothena (PRTA) Heavy US$244 Million Annual Loss Tests Bullish Profitability Narratives - Sahm
Prothena Posts Q1 Earnings as Revenues Surge on Milestone Payment - Yahoo Finance
Prothena (PRTA) Highlights Progress in Parkinson's Research and Collaborations - GuruFocus
Citizens raises Prothena stock price target on milestone payment By Investing.com - Investing.com UK
Prothena (PRTA) Revises 2026 Cash Outlook and Operating Expenses - GuruFocus
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):